Moderna Inc
MRNA
Market Cap$50.85B
Close$
$-72.53
154.7% downside
Current Fair Value
154.7% downsideOvervalued by 154.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $50.85 Billion |
|---|---|
| Enterprise Value | $42.90 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-15.86 |
| Beta | 1.17 |
| Outstanding Shares | 383,239,726 |
| Avg 30 Day Volume | 3,587,723 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.52 |
|---|---|
| PEG | 0.54 |
| Price to Sales | 10.21 |
| Price to Book Ratio | 4.02 |
| Enterprise Value to Revenue | 8.33 |
| Enterprise Value to EBIT | -8.35 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data
About Moderna Inc
CEO: Stephane Bancel